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Summary
Objective Male patients with the X-linked IGSF1 deficiency
syndrome are characterized by central hypothyroidism, delayed
pubertal testosterone rise, adult macroorchidism, variable pro-
lactin deficiency and occasionally transient partial growth hor-
mone deficiency. Thyroid hormone plays a vital role in brain
development and functioning, and while most patients receive
adequate replacement therapy starting shortly after birth, it is
unknown whether this syndrome is accompanied by long-term
impaired cognitive functioning. We therefore assessed cognitive
functioning in male patients with IGSF1 deficiency.
Methods Fifteen adult male patients with IGSF1 deficiency
participated in neuropsychological assessment of executive
functioning and memory, and completed validated question-
naires on health-related quality of life (HRQoL), mood and
fatigue. Results were compared to data from previous studies
by our department: 54 healthy controls (76 for the attention
task) for the test battery and 191 healthy controls for the
questionnaires.
Results All patients had central hypothyroidism, and twelve
were treated with levothyroxine. Patients performed worse than
controls in tasks that required attentional control (Trail Making
Test, Letter-Digit Substitution Test, and Sustained Attention to
Response Task) (all P < 0001). Memory was unaffected. In
addition, patients reported more mental fatigue and reduction
of activity (Multidimensional Fatigue Inventory) (both
P < 001), while HRQoL and mood reports were not different
from controls. Age at the start of replacement therapy and cur-
rent thyroxine levels were not related to outcome.
Conclusions Adult male patients with IGSF1 deficiency exhibit
mild deficits in attentional control on formal testing. This
finding was not related to the age at start of replacement ther-
apy, or current levothyroxine treatment.
(Received 10 August 2015; returned for revision 2 September
2015; finally revised 10 September 2015; accepted 15 September
2015)
Loss of function of the immunoglobulin superfamily member
1 (IGSF1) gene causes an X-linked endocrine syndrome in
males, characterized by congenital central hypothyroidism, a
delayed pubertal testosterone rise despite normal timing of
testicular enlargement, adult macroorchidism, and in some
cases prolactin or transient partial growth hormone (GH)
deficiency.1,2
Thyroid hormone plays a vital role in brain development
and functioning, and an altered thyroid hormone state has
been associated with abnormal cognitive functioning in chil-
dren and adults.3 Although many aspects of endocrine dys-
function in IGSF1 deficiency have been studied, cognitive
functioning was not assessed. In our experience, patients with
IGSF1 deficiency often report attention problems in daily life,
for example while studying for exams, playing sports like tennis
and even when having a conversation. These problems had
been present for as long as they could remember and were
often recognized by relatives and treating physicians. Indeed,
five of the 32 male patients with IGSF1 deficiency currently
known to our group, who are all younger than 25 years, had
been diagnosed with attention-deficit disorder (ADD), and two
of them had been treated with psychostimulants (unpublished
data). In addition to these observations, the penetrance of
levothyroxine in target tissues in this genetic syndrome has
been doubted.4
This study aimed to investigate cognitive functioning, specifi-
cally executive functioning and memory, in adult male patients
with the X-linked IGSF1 deficiency syndrome. Patients were
invited for neuropsychological examination, and completed vali-
dated questionnaires assessing health-related quality of life
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(HRQoL), mood and fatigue. Results were compared to healthy
controls.
Subjects and methods
Design
Cognitive functioning was assessed in 15 patients with docu-
mented IGSF1 deficiency. The neuropsychological examination
started at 9:00 AM, and patients were instructed not to drink
coffee that morning. During the week following the examina-
tion, the patients completed several questionnaires at home
assessing HRQoL, mood and fatigue. Cognitive performance and
questionnaire scores of patients were compared to control data
from previous studies performed in our institution using similar
protocols.
Patients and healthy controls
Inclusion criteria were Dutch male patients between 18 and
75 years old with documented pathogenic mutations in IGSF1
(n = 18). Pathogenicity was based on the presence of central
hypothyroidism, phenotype–genotype segregation, and in silico
and in vitro pathogenicity of the mutated proteins, as previously
described.1 Three patients chose not to participate because of
long travelling distance; thus, we included 15 patients with
IGSF1 deficiency. Results were compared to data from healthy
male controls between 18 and 75 years old: for the cognitive
tasks from 54 subjects,5–7 for the sustained attention to response
task (SART) from 76 subjects7,8 and for the questionnaires from
191 subjects.9
Methods
Cognition – executive functioning. The Trail Making Test
involves scanning, visuomotor tracking, divided attention and
cognitive flexibility. The patient has to connect digits with each
other (Trail A), followed by connecting digits and letters (Trail
B). The time that was used for each trail was noted, with more
time used indicating lower performance.10
The Stroop Color-Word Test was used to measure interfer-
ence sensibility. One response (reading the word) should be
inhibited in order to name the colour of the ink, which leads to
a delay in reaction time.11 The number of correct responses
within 45 s was counted.
The Letter-Digit Substitution Test measures visual scanning,
cognitive flexibility, sustained attention, psychomotor speed and
speed of information processing.12 The number of letters cor-
rectly substituted for digits within 60 s was counted.
The FAS Test was used to assess verbal mental flexibility and
fluency by testing the ability to produce as many words as possi-
ble with a specific starting letter (F, A or S).13 The number of
correctly produced words within 60 s was counted.
The Sustained Attention to Response Task (SART) is a test of
attentional control assessing both attentional and inhibitory pro-
cesses by addressing the capacity to attend to a situation or task
in spite of distractibility, fatigue or boredom.14 After a practice
run, numbers from 1 through 9 appeared in random order and in
different sizes in a white font on a black computer screen for
4 min and 20 s, 225 times in all. Participants were asked to press
a button in response to the appearance of each number, except
when the number was a ‘3’, which occurred 25 times. Participants
were instructed to give equal importance to accuracy and speed
in performing the task. The primary outcome was the total num-
ber of errors, consisting of errors of commission (i.e. pressing
after a ‘3’) and errors of omission (i.e. not pressing after any
number but a ‘3’). A secondary outcome measure was reaction
time (i.e. the response time after the appearance of a number)
and variability in reaction time. The test took place in solitude in
a quiet room. The SART was performed two times to correct for
the learning effect, and only the second run was used.14 The time
in between was spent on other tests (Rey Complex Figure, FAS,
Letter-Digit Substitution Test, Stroop Color-Word Test).
Cognition – memory. The Wechsler Memory Scale (WMS) was
used to assess learning, memory and working memory using
auditory and visual stimuli. Higher scores reflect better memory
performance.15
The Verbal Learning Test of Rey measures verbal memory and
learning and consists of three trials in which fifteen words are
presented visually. In addition, there is a fourth delayed repro-
duction. The number of correctly recalled words was counted
for each trial. Producing more words in each trial indicates a
better learning capacity.16
The Rey Complex Figure is a drawing and visual memory test
and measures visual-motor organization by examining the ability
to copy and remember a complex figure. Immediate recall and
delayed recall are measured, and higher scores indicate better
visual memory.17
Questionnaires. The Short Form-36 (SF-36) assesses general
well-being and functional status during the previous 30 days.18
The SF-36 contains nine dimensions, and scores are expressed
on a 0–100 range. Because the HADS and the MFI-20 are more
specific for mental health and fatigue, assessment of the
dimensions ‘vitality’ and ‘general mental health’ from the SF-36
was not performed. Because the nine scales are scored separately
from exclusive item-specific questions, the results of the scales
presented in this study are not influenced by the two
dimensions that were left out in this evaluation. Scores are
expressed on a 0–100 scale, higher scores being associated with
better quality of life.
The Hospital Anxiety and Depression Scale (HADS) assesses
anxiety and depressive symptoms.19 Scores range from 0 to 21,
with higher scores indicating more complaints.
The Multidimensional Fatigue Inventory (MFI-20) assesses
fatigue in five dimensions.20 Dimension scores vary from 0 to
20, with higher scores reflecting greater fatigue.
Laboratory measurements. Free T4, prolactin, cortisol and
testosterone levels were measured by electrochemoluminescent
immunoassays (ECLIA), using a Modular E170 (Roche
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Diagnostics, Mannheim, Germany). The maximal interassay
coefficient of variation (CV) for these hormones was 50%.
Serum IGF-I concentrations in nmol/l were measured using an
iSYS immunoanalyser of IDS GMBH in Frankfurt am Main,
Germany. The IGF-I assay is standardized against the first
international standard 02/254. The intra-assay CV values at
mean plasma levels of 65 and 14 nmol/l were between 62 and
68%, respectively. Serum GH was measured on an Immulite
2000 XPi system (Siemens Healthcare Diagnostics, Deerfield, IL,
USA). Measured mU/l was converted to lg/l using a division
factor of 26. Analytical variation at 5 and 25 mU/l were 52%
and 45%, respectively.
Statistical analysis
Group differences were compared using the two-tailed indepen-
dent Student’s t-test or, in case the assumption of normality was
not met (Shapiro–Wilk test), the Mann–Whitney U-test. Categor-
ical data were compared using the chi-square test or, when the
expected cell count was <5, the Fisher’s exact test. Linear regres-
sion models were used to correct for differences in age and educa-
tion in the cognitive tasks, age and reaction time in the SART,
and age in the questionnaires. To correct for multiple testing, dif-
ferences were considered statistically significant at P < 001.
Results
Clinical characteristics
We included fifteen adult male patients from ten unrelated fam-
ilies (Table 1). Median age was 254 years old (range 194–
677 years). All were diagnosed with central hypothyroidism,
and twelve of them were on stable levothyroxine replacement.
Five patients started levothyroxine treatment shortly after birth,
four in childhood, one in adolescence and the remaining two at
middle age. The remaining three patients were recently diag-
nosed in adulthood, did not show overt signs or symptoms of
hypothyroidism and were studied in the untreated condition.
Eight patients were prolactin deficient, and GH deficiency was
present in one patient who was treated with rhGH. One 25-
year-old patient was diagnosed with ADD in adolescence. He
was treated with psychostimulants while studying for high
school graduation, but stopped afterwards because of side
effects. Brain MRI was previously performed in five patients,
showing a frontoparietal hygroma in one patient (present at
birth and treated with a ventriculoperitoneal shunt), but no
abnormalities in the others. Exclusion of the patient with ADD
and/or the patient with hygroma did not change the results.
All controls were healthy males between 18 and 75 years old.
Mean age in controls was generally higher than that in patients;
thus, we corrected for age using regression analysis.
Cognition – executive functioning
Patients performed worse in several executive functioning tasks
(Table 2). Compared with controls and corrected for age and
education, patients were significantly slower in completing both
trails A and B of the Trail Making Test (both P ≤ 0001), and
substituted fewer words within one minute on the Letter-Digit
Substitution Test (b = 78 (SE 22), P = 0001).
Furthermore, patients performed markedly worse than con-
trols on the SART (Table 3), as they made more errors of omis-
sion (P = 0001) and commission (P < 0001). Variability in
reaction time was greater in patients than controls (P < 0001).
As patients’ reaction time tended to be quicker, possibly influ-
encing the error rates,14 we corrected for reaction time as well as
age, which did not change the results: patients made more than
twice as many mistakes as controls (118 more mistakes, 95% CI
84–152). Results were unavailable in one patient due to failure
of the device to automatically store results. Neither free T4
levels, nor age of start of replacement therapy correlated with
executive functioning (corrected for age and education).
Patients’ performance in the Verbal Fluency Test and Stroop
Color-Word test was not different from controls.
Table 1. Clinical characteristics of IGSF1-deficient male patients
Patients
Reference
range
Mean  SD or
median (IQR) Range
n 15
Age (year) 254 (229–567) 189–677
BMI (kg/m2) 280  54 221–395
Central
hypothyroidism
15
Free T4 at
diagnosis (%LL)
821  102 658–954 >100%
TSH at
diagnosis (mU/l)
2300  1361 0800–5600 0300–4800
Levothyroxine
replacement
12
Growth hormone
deficiency
1
RhGH
replacement
1
Free T4 (pmol/l) 143  51 79–257 120–220
TSH (mU/l) 0850  0671 <001–2270 0300–4800
IGF-1 (SDS) 12  15 Age dependent
(in-house)
Basal GH (lg/l) 11  15 00–28
Prolactin (lg/l) 63  41 40–150
Testosterone
(nmol/l)
157  57 80–310
Cortisol
(lmol/l)*
0394  0169 0100–0600
Testicular
volume (SDS)†
39  22 40
IQR, interquartile range; %LL: percentage of the lower limit of the age-
specific reference range. All measurements were taken at the time of the
study, except for free T4 at diagnosis and TSH at diagnosis.
*Early morning cortisol level.
†Ultrasonographic volume (p/6lengthheightwidth) of largest testis.
SDS: standard deviation score.
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Cognition – memory
Memory function was normal in patients, as they performed
similar to controls in the WMS, the Verbal Learning Test of Rey
and the Rey Complex Figure Test (Table 2). Initial differences
between patients and controls in the WMS subscale visual mem-
ory did not persist after correction for age and education.
Questionnaires
Patients reported more mental fatigue and a reduction in activ-
ity in the MFI-20 (both P < 001, corrected for age) (Table 4).
No significant differences were observed in patients’ responses in
the SF-36 or HADS. Neither free T4 levels nor age at start of
replacement therapy was associated with outcome after correct-
ing for age.
Discussion
The present study demonstrates that patients with IGSF1 defi-
ciency have mild deficits in attentional control with preserved
memory function. Furthermore, patients reported more mental
fatigue and a reduction in activity, while HRQoL and mood esti-
mates were not affected.
Adult patients with IGSF1 deficiency performed worse than
controls in tests that primarily assess attentional processes (the
Trail Making Test, Letter-Digit Substitution Test and SART).
The Trail Making and Letter-Digit Substitution Test are paper-
and-pencil speed tests that require perceptual-motor speed or
focussed attention to scan and select target information from an
array rapidly and efficiently, and make a skilled manual response
quickly (also known as ‘focus-execute’ attention21). The SART
Table 2. Cognitive tasks
Patients Controls P b* (SE) P
n 15 54
Age (year) 361  188 555  118 0001
Male gender 15 54 1000
Education level†
High 8 (53%) 18 (33%) 0138
Intermediate 6 (40%) 19 (35%)
Low 1 (7%) 17 (32%)
Executive functioning
Verbal fluency test, no. of correct 353  78 346  134 0839 12 (43) 0774
Trail making test
Trail A, time (min) 046  013 040  021 0018 02 (01) 0001
Trail A, no. of errors 04  05 02  04 0083 02 (01) 0245
Trail B, time (min) 115  051 111  053 0771 05 (01) <0001
Trail B, no. of errors 04  05 08  12 0418 00 (03) 0932
Letter-digit substitution test
No. of correct 299  66 326  74 0218 78 (22) 0001
No. of errors 01  05 01  02 0829 01 (01) 0473
Stroop color-word test, interference total 447  102 401  99 0033 38 (28) 0190
Memory
Wechsler memory scale
MQ 1146  158 1163  144 0700 13 (47) 0778
Information 60  00 59  02 0350 01 (01) 0441
Orientation 50  00 50  00 1000 00 (00) 1000
Concentration 77  21 73  18 0193 05 (06) 0376
Digit span 121  38 99  16 0038 15 (08) 0062
Logical memory 75  28 74  27 0967 07 (09) 0450
Visual memory 122  19 92  35 0001 09 (10) 0359
Associative learning 164  32 166  27 0971 18 (09) 0049
Verbal learning test of Rey
Imprinting, total no. 58  22 53  18 0331 04 (06) 0523
Immediate, total no. 89  22 86  21 0644 09 (07) 0181
Immediate 2, total no. 105  22 98  22 0286 07 (07) 0364
Delayed, total no. 83  28 80  28 0762 12 (09) 0200
Rey complex figure test
Immediate 246  55 209  66 0046 01 (20) 0964
Delayed 239  56 209  62 0098 08 (19) 0684
Data represent number (percentage) or mean  SD, unless specified otherwise. *Linear regression model assessing the effect of disease, corrected for
age and education. †Low: primary education (elementary school) and lower secondary education (preparatory secondary education); Intermediate:
higher secondary education (higher general continued education, pre-university secondary education) and postsecondary education (intermediate voca-
tional education); High: tertiary education (higher professional education, university). Statistically significant differences (P < 001) are marked in bold.
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was designed to test sustained attention, that is the capacity to
maintain focus and alertness over time (also known as ‘vigi-
lance’21). However, the SART also requires focussed attention
and inhibition (withholding a pre-potent response,21 for example
commission errors), and the Trail Making and Letter-Digit Sub-
stitution Test also require sustained attention,21 as all of these
attentional processes are highly interdependent. We therefore
chose to classify the observed alterations using the overarching
construct of top-down control or co-ordination of action within
the network of structures responsible for complex goal-oriented
behaviour known as ‘attention control’.22
The Stroop Color-Word Test also requires attentional con-
trol.21 Although patients performed slightly worse than controls
in this test, differences were not statistically significant. This
inconsistency with the Trail Making and Letter-Digit Substitu-
tion Test might be explained by the required response being ver-
bal rather than manual. Mental flexibility (Verbal Fluency Test)
was normal.
Reductions in attentional control were also experienced sub-
jectively by patients, as they reported more problems in the
MFI-20 subscales mental fatigue (i.e. ‘When I am doing some-
thing, I can keep my thoughts on it/My thoughts easily wander’
and ‘I can concentrate well/It takes a lot of effort to concentrate
on things’) and reduction in activity (i.e. ‘I feel very active’ and
‘I think I do a lot in a day/I think I do very little in a day/I get
little done’). As patients reported no disturbances of general and
physical fatigue in the MFI-20, nor of physical functioning in
the SF-36, the observations are unlikely explained by physical
Table 3. Sustained attention to response task (executive functioning)
Patients Controls P value b* (SE) P value
n 14† 76
Age 368  193 456  128 0072
Male gender 15 76 1000
Errors of omission 60  66 09  18 0001 47 (09) <0001
Errors of commission 188  35 102  48 <0001 70 (12) <0001
Total no. of errors 248  92 111  59 <0001 118 (17) <0001
Mean RT (ms) 2508  452 2773  428 0082
RT variability (ms) 1382  690 691  271 <0001
Data represent mean  SD or beta coefficient (SE). *Linear regression model assessing the effect of disease, corrected for age and reaction time.
†Results from one patient were unavailable. RT, reaction time. Statistically significant differences (P < 001) are marked in bold.
Table 4. Questionnaires on health-related quality of life, mood and fatigue
Patients Controls P value b* (SE) P value
n 15 191
Age 361  190 534  126 0001
Male gender 15 191 1000
SF-36
Physical functioning 917  202 917  128 0290 62 (36) 0084
Social functioning 900  172 937  134 0221 61 (39) 0118
Role physical problem 817  383 905  228 0787 114 (68) 0098
Role emotional problem 822  330 917  224 0206 91 (66) 0170
Pain 896  227 896  149 0958 60 (44) 0164
General health perception 763  213 739  158 0238 34 (45) 0442
Health change 550  194 534  161 0727 07 (47) 0881
HADS
Anxiety 44  36 32  25 0285 09 (07) 0229
Depression 28  34 26  27 0839 09 (08) 0244
Total 72  68 58  43 0787 18 (13) 0170
MFI-20
General fatigue 94  43 74  35 0054 17 (10) 0086
Physical fatigue 78  45 72  33 0880 13 (10) 0172
Reduction in activity 93  43 70  31 0019 27 (09) 0003
Reduction in motivation 77  36 69  31 0394 10 (09) 0255
Mental fatigue 120  52 71  32 <0001 48 (10) <0001
Data represent mean  SD or beta coefficient (SE). *Linear regression model assessing the effect of disease, corrected for age. Statistically significant
differences (P < 001) are marked in bold.
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tiredness. These complaints may be a consequence of the deficits
in attentional control, or share a common aetiology with these
deficits.
Nevertheless, the clinical significance of the observations for
patients is hard to assess. As IGSF1 deficiency is congenital,
functioning cannot be compared to a predisease state. Further-
more, attention was sufficient to perform well in tasks of mem-
ory in the WMS, the Verbal Learning Test of Rey and the Rey
Complex Figure Test, as well as mental flexibility in the Verbal
Fluency Test. Also, while some reported problems with concen-
trating during consultations, most patients did not consult a
professional for complaints of attentional control, educational
level was normal and matched current profession, and differ-
ences with the controls’ mean were often less than two standard
deviations scores (Trail Making Test: 10  03 SDS, Letter-Digit
Substitution Test: 11  03 SDS, SART errors of omission:
26  05 SDS and commission: 15  03 SDS, MFI-20 reduc-
tion in activity: 09  03 SDS and mental fatigue: 15  03
SDS). We therefore consider the symptoms to be mild.
Our results are in good accordance with several studies in
children with (early treated) congenital hypothyroidism that
report disturbances of especially the attention components
focussed attention, inhibition and sustained attention,23–25 espe-
cially in those with prematurity or the lowest plasma or serum
T4 concentrations in the neonatal period.
26–28 Therefore, the
difficulties with attentional control in patients with IGSF1 defi-
ciency might be related to inadequate (prenatal) T4 concentra-
tions during critical periods of brain maturation, rather than to
abnormal T4 concentrations in adulthood. This is supported by
the absence of a correlation between executive functioning and
either free T4 concentrations or age of start of replacement ther-
apy in the IGSF1-deficient patients. Moreover, adults with
acquired primary hypothyroidism usually report symptoms of
anxiety and depression (which were not present in patients with
IGSF1 deficiency), and rarely present with problems in the cog-
nitive domain,29 although some studies reported impaired (sus-
tained) attention in patients treated for autoimmune
hypothyroidism while not in other causes of acquired primary
hypothyroidism.30,31 On the other hand, direct effects of IGSF1
on adult executive functioning cannot be excluded, as IGSF1 is
expressed in the adult rat cerebral cortex, striatum, subfornical
organ, amygdala and in glial cells of the hypothalamus.32
Although IGSF1’s function in these brain regions is still
unknown, other members of the Ig superfamily are involved in
the development and maintenance of various parts of the central
nervous system.33,34
Of special interest are patients with generalized resistance to
thyroid hormone (GRTH), a disorder caused by mutations in
the thyroid hormone receptor beta (THRB) gene, characterized
by reduced responsiveness of peripheral and pituitary tissues to
thyroid hormone. Forty-eight to 73% of these patients have been
found to show attention-deficit/hyperactivity disorder.35 Several
studies confirmed the relation between this defect and especially
sustained attention and ADD, which might be related to higher
glucose metabolism in the right parietal cortex and anterior cin-
gulate gyrus.36 Treatment with liothyronine sodium, and not
levothyroxine, improved these complaints.37 Moreover, TRB
knockout mice show disturbances of sustained attention and are
used as a model for ADD.38 In our adult patient group, we
observed no relation between outcome and T4 concentrations at
the time of evaluation or the age of start replacement therapy,
raising the question whether the current treatment in these
patients is sufficient. The pathophysiology of IGSF1 deficiency is
still unresolved, but given the similarities with GRTH, it would
be interesting to treat these patients with liothyronine and re-
evaluate cognitive functioning.
Besides congenital central hypothyroidism, a number of
patients with IGSF1 deficiency exhibit persistent prolactin defi-
ciency or transient partial GH deficiency in childhood. There are
no reports of associations between these conditions and vigi-
lance. We also previously reported a frontoparietal hygroma, a
small pituitary stalk lesion and hypoplasia of the corpus callo-
sum in three of eleven brain MRI studies in IGSF1-deficient
patients.1 Associations between callosal efficiency and vigilance
have been reported.39 However, as the integrity of the corpus
callosum was normal in all other MRI’s, callosal inefficiency is
unlikely to explain the profound disturbances observed in
patients with IGSF1 deficiency.
An obvious limitation of this study is its small group size,
which is inherent to the low prevalence of IGSF1 deficiency. A
second limitation is that we did not include a matched control
group. However, we were able to select large groups of controls
that were studied with similar protocols in our institution, and
corrected for differences in age or education level. We contend
that the observations are both clear and informative.
In conclusion, this first study on cognitive functioning of
adult male patients with the X-linked IGSF1 deficiency syn-
drome showed that these patients exhibit mild deficits in atten-
tional control with preserved memory function. Furthermore,
patients reported more mental fatigue and reduced activity.
These results resemble findings in other congenital disorders
involving thyroid hormone, especially GRTH, but were not
related to current treatment with levothyroxine or the age at
which replacement therapy was initiated. Future research in (ju-
venile) patients and animal models is needed to further elucidate
whether these deficits are caused by irreversible damage from
intra-uterine hypothyroxinaemia, or whether they are related to
decreased sensitivity to treatment with levothyroxine. Either
way, physician awareness of the presence of these deficits in
patients with IGSF1 deficiency may be helpful during consulta-
tions. If necessary, neuropsychological interventions or treatment
with psychostimulants may be considered.
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